Since the Subcommittee for Development of Benefits and Service system under the Universal Coverage Scheme, the National Health Security Office considers that there are health measures not included in the health benefit package under the universal coverage scheme. Some measures are already in the benefits package, but they are expensive and service

This study aims to explore effectiveness of home visit on clinical, economic, and humanistic outcomes employing systematic review. Home visits for all diseases and within all patient groups are included, provided that inclusion criteria are met. Results are expected to be useful for (1) developing guidelines for home visit for health professionals,

This is an intervention study research covers 18 districts in two provinces in the North of Thailand aiming at measuring effects of interventions. Three interventions are developed, namely (1) provision of supporting suicide prevention tools/guidelines for health volunteer and community leaders, (2) development of existing hotline and (3) use of co

Background: Osteoporosis, a reduction in bone strength, is one of the most significant factors contributing to fractures, particularly in postmenopausal women. It affects not only patients’ life expectancy and quality of life, but also household expenditure on healthcare costs. Various screening methods to identify the risk of developing osteopo

Introduction: Cervical cancer is a major cause of deaths in female in low- and middle-income countries. The disease is preventable by introducing screening tests such as Pap smears, visual inspection with acetic acid (VIA) and HPV DNA testing. Recently, the first vaccine against human papillomavirus (HPV) was introduced to the health care market t

The Cost-utility analysis (CUA) study of Hematopoietic stem cell transplantation (HSCT) versus blood transfusion and iron chelating therapy (standard treatment) found that related HSCT (sibling donor) is more cost effective than unrelated HSCT in patients ≤ 10 years old in Thai healthcare setting. However, there currently has capacity limit for H

Economic evaluation of HLA-B*1502 screening for preventing carbamazepine- induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is prioritized by stakeholders under ‘Research for development of health benefit package under universal coverage scheme’. The study carried out an evidence to inform the Subcommittee for Developm

Following an assessment1 of the core strategies of HITAP carried out by a team of Thai and UK investigators in 2007-2008, at the request of the Thai Health Promotion Foundation, HITAP has initiated a second evaluation, in 2011, this time bringing together a team of UK, Thai and Korean assessors. These recommendations were the result of data analysi

The Union of Myanmar is the largest country in mainland South-East Asia with a population of 57.5 million. It has a pluralistic mix of public and private healthcare systems. Although the Ministry of Health (MoH) is the main organisation responsible for healthcare provision, 70-80% of health service expenditure is now absorbed by the households. Thi

Introduction: The development of new technology to treat patients with metastatic renal cell carcinoma has resulted in promising outcomes in terms of extending life and improving quality of life. In Thailand, where health resources are limited, an economic evaluation of such technology would provide useful information for pricing and reimbursement